Leadership Overview
Baxter has 6 executives leading key functions including information technology, finance, marketing, quality assurance, and infusion therapies.
Driven by innovation, Baxter is dedicated to developing and manufacturing medical devices, pharmaceuticals, and hospital care products that improve patient outcomes globally.
Driven by innovation, Baxter is dedicated to developing and manufacturing medical devices, pharmaceuticals, and hospital care products that improve patient outcomes globally.
Leadership Roles at Baxter
Anita Zielinski - Senior VP, Controller & Chief Accounting Officer & Interim Chief Financial Officer
Anita Zielinski, the Senior VP, Controller & Chief Accounting Officer & Interim Chief Financial Officer at Baxter, manages the company's comprehensive financial reporting and accounting operations. This executive oversees all aspects of financial control, ensuring accuracy and compliance with global accounting standards. As Interim Chief Financial Officer, Anita Zielinski provides critical financial leadership, guiding strategic financial planning and resource allocation. The role involves safeguarding company assets and optimizing financial performance across all business units. This leadership ensures the integrity of financial data, supporting informed decision-making for sustainable growth. Anita Zielinski's oversight extends to managing financial risks and identifying opportunities for fiscal improvement. The objective is to maintain robust financial health and drive shareholder value through disciplined financial management.
Cecilia Soriano - Group President, Infusion Therapies Technologies & Pharmaceuticals
Cecilia Soriano, the Group President, Infusion Therapies Technologies & Pharmaceuticals at Baxter, spearheads the strategic growth and operational execution for key business segments. This leadership position involves overseeing the development, manufacturing, and commercialization of infusion systems, advanced drug delivery technologies, and pharmaceutical products. Cecilia Soriano drives innovation and market expansion within these critical areas, ensuring Baxter's offerings meet evolving healthcare needs globally. The focus is on enhancing patient outcomes through superior product performance and accessibility. Soriano's purview includes managing cross-functional teams to achieve ambitious business objectives and maintain Baxter's leadership in therapeutic solutions. This involves fostering strategic partnerships and optimizing supply chains to ensure reliable delivery of essential medical products worldwide.
Stacey Eisen - Senior Vice President, Chief Communications Officer and Corporate Marketing, and President, Baxter Foundation
Stacey Eisen, the Senior Vice President, Chief Communications Officer and Corporate Marketing, and President, Baxter Foundation at Baxter, directs the company's global communications strategy and corporate marketing initiatives. This executive shapes Baxter's public image and brand narrative, ensuring consistent messaging across all platforms. Stacey Eisen also leads the Baxter Foundation, driving philanthropic efforts and community engagement. The role involves overseeing internal and external communications, public relations, and brand management to support Baxter's mission of advancing healthcare. By integrating corporate marketing with strategic communications, Eisen enhances stakeholder relationships and reinforces Baxter's commitment to social responsibility. This leadership ensures that Baxter's contributions to global health are effectively communicated and recognized worldwide.

Olga Selina - Vice President, Information Technology Artificial Intelligence (Ai) & Data, Medical Products & Therapies Information (Segment Technology Leader & Chief Information Officer
Olga Selina, the Vice President, Information Technology Artificial Intelligence (Ai) & Data, Medical Products & Therapies Information (Segment Technology Leader & Chief Information Officer at Baxter, directs the strategic implementation of artificial intelligence and data analytics across the Medical Products & Therapies segment. This leadership role involves architecting advanced data solutions and AI-driven insights to enhance product development and operational efficiency. Overseeing the technology roadmap for this critical segment, Olga Selina ensures alignment with Baxter's broader mission of delivering innovative healthcare solutions. The focus remains on leveraging cutting-edge technology to improve patient care and streamline healthcare delivery. This involves close collaboration with R&D and commercial teams to translate data potential into tangible product enhancements and market advantages. The objective is to solidify Baxter's position as a leader in data-informed medical technology.
Rusty Patel - Senior Vice President & Chief Information Officer
Rusty Patel, the Senior Vice President & Chief Information Officer at Baxter, directs the global information technology strategy and infrastructure. This leadership role encompasses overseeing all aspects of IT operations, cybersecurity, and digital transformation initiatives. Rusty Patel ensures that technology solutions effectively support Baxter's business objectives, including the development and manufacturing of medical devices and pharmaceuticals. The focus is on building resilient and scalable IT systems that enhance operational efficiency and data security across worldwide operations. By driving innovation in IT, Patel aims to empower employees and improve the delivery of healthcare products. This involves managing a complex technology portfolio and fostering a culture of continuous improvement within the IT department. The ultimate goal is to leverage technology to advance Baxter's mission of saving and sustaining lives.

Vinod Shewale - Global Chief Marketing Officer, Quality Assurance & External Contract Manufacturing Quality Compliance
Vinod Shewale, the Global Chief Marketing Officer, Quality Assurance & External Contract Manufacturing Quality Compliance at Baxter, leads the strategic direction for global marketing efforts while ensuring stringent quality standards. This dual focus involves driving market penetration for Baxter's diverse portfolio of medical devices and pharmaceuticals, alongside overseeing critical quality assurance processes. Vinod Shewale's responsibilities include enhancing brand visibility and market share through innovative marketing campaigns and ensuring compliance with rigorous quality regulations in manufacturing and external contract operations. The role demands a deep understanding of both market dynamics and operational excellence. Shewale works to align marketing strategies with product quality and manufacturing integrity. This ensures that Baxter's offerings meet the highest standards of safety and efficacy for healthcare providers and patients worldwide.
Explore Leadership Teams in Manufacturing
Cipla Limited is a global pharmaceutical company based in Mumbai, India, with operations in India, the United States, South Africa, and other international markets. Through its Pharmaceuticals and New Ventures segments, the company develops, manufactures, markets, and distributes a broad range of generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and finished formulations. Its products address multiple therapeutic areas, including cardiovascular disease, pulmonary and kidney conditions, neurological and psychiatric disorders, HIV/AIDS, respiratory and asthma care, oncology, diabetes and metabolic disorders, infectious diseases, critical care, women’s health, ophthalmology, and child health. In addition to its core pharmaceutical portfolio, Cipla is active in consumer healthcare, biosimilars, and specialty medicine businesses. Founded in 1935, Cipla has grown into a major global healthcare player.
Company Leadership GJ
LV
LB
Founded in 1989, Macleods Pharmaceutical develops and manufactures generic pharmaceuticals. The Company offers tablets, drugs, syrup, and other related products. The company is headquartered in Mumbai, Maharashtra, India.
Company Leadership AP
BP
AM
AS
Crinetics is a pharmaceutical company that develops much-needed therapies for people with endocrine diseases. Were here for patients who are eager to find therapies that provide effective disease control and more simplicity in their lives. We partner with healthcare practitioners to ensure were solving real problems for them. And we build value in the company for investors by filling real market needs. Whatever brought you here, welcome.
Company Leadership NL

NB
Founded in 1850 and headquartered in Johannesburg, South Africa, Aspen Pharmacare Holdings Limited is a global specialty and branded pharmaceutical company headquartered in Durban, South Africa. Operating across Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia, Aspen focuses on sterile injectables (including anaesthetics, anticoagulants, antithrombotics, analgesics, and hormone replacement therapies), over-the-counter medicines, and prescription products for conditions such as hypothyroidism, autoimmune disease, pain, gout, and inflammatory disorders. The company also manufactures active pharmaceutical ingredients and finished dose forms, including steriles, oral solids, liquids, semi-solids, biologicals, and heparins, supplying both its own brands and third-party customers worldwide.
Company Leadership
TS

RM